Flu Season in France: A Regional Snapshot and Future Trends
While France is seeing a decrease in flu-related healthcare visits across all age groups, the virus remains actively circulating. According to recent reports from Santé Publique France, the positivity rate remains above 10%, driven by influenza A(H3N2) and A(H1N1) strains. This situation prompts a look at regional variations and potential future developments.
Burgundy-Franche-Comté: A Regional Hotspot
The Burgundy-Franche-Comté region is currently experiencing particularly high rates of influenza. SOS Médecins data from the last week of January 2026 indicates that 14.4% of consultations resulted in a diagnosis of flu or flu-like syndrome. This places the region among those with the highest rates in France, alongside Occitanie, Hauts-de-France, Provence-Alpes-Côte d’Azur, Martinique, and Grand Est.
The incidence varies by age group within the region: 13% among children aged 0-4, a higher 21.1% for those aged 5-14, 13.7% for 15-64 year olds, and 7.2% for those 65 and over. Nationally, the positivity rate in general practice has decreased from 54% to 40.5%.
Hospital Activity and Hospitalizations
Hospital activity related to the flu is showing a slight decline in Burgundy-Franche-Comté. As of late January, 329 out of 10,000 emergency room visits were directly attributable to the flu – a lower figure than observed in the same period in the previous two years.
The proportion of hospitalizations for influenza remains stable at 3.1% regionally. However, a slight increase is noted among individuals aged 15-64, rising from 3.6% to 3.9% within a single week.
Vaccination Efforts and Strain Mismatch
To mitigate severe cases, the vaccination campaign has been extended to the end of the month for vulnerable populations. As of December 31, 2025, national vaccination coverage reached 46.3% of the target population. However, the effectiveness of the vaccine is considered moderate due to a significant difference between the circulating K subclade and the A(H3N2) strain used in the vaccine formulation.
Data indicates that the vast majority of flu-related deaths – 94.6% – have occurred in individuals aged 65 and older, with 5.2% in the 15-64 age group and only 0.2% in children under 15.
Looking Ahead: Potential Future Trends
The current situation highlights the ongoing challenge of influenza and the importance of continued surveillance. The dominance of the K subclade suggests a necessitate for improved vaccine matching in future seasons. The relatively low vaccination coverage also underscores the need for increased public health messaging and efforts to improve vaccine uptake, particularly among at-risk groups.
The observed regional variations suggest that localized outbreaks and higher incidence rates are likely to persist. Continued monitoring of hospital capacity and emergency room visits will be crucial for managing the impact of the flu season.
FAQ
Q: Is the flu vaccine still effective?
A: While the vaccine offers some protection, its effectiveness is reduced due to a mismatch between the circulating strain and the vaccine formulation.
Q: Who is most at risk from the flu?
A: Individuals aged 65 and over are at the highest risk of severe illness and death from the flu.
Q: What should I do if I suspect I have the flu?
A: Consult a healthcare professional for diagnosis and treatment. Rest, stay hydrated, and avoid contact with others to prevent spreading the virus.
Q: How long will the flu season last?
A: Flu season typically peaks between December and February, but activity can continue into the spring.
Did you know? The influenza virus is constantly evolving, which is why the vaccine composition is updated annually.
Pro Tip: Practicing good hygiene, such as frequent handwashing and covering coughs and sneezes, can help prevent the spread of the flu.
Stay informed about the latest developments in the flu season by visiting the Pasteur Institute website and Santé Publique France.
What are your thoughts on the current flu situation? Share your experiences and questions in the comments below!
